Global Thyroid Function Test Industry to Hit US$ 2.64 Billion by 2033, Sustaining a Remarkable 4.2% CAGR | FMI

The Global Thyroid Function Test Industry, currently valued at an impressive US$ 1.75 billion in 2023, is on the brink of significant expansion, with projections indicating a remarkable surge to US$ 2.64 billion by the year 2033. This noteworthy development is fueled by a steadfast Compound Annual Growth Rate (CAGR) of 4.2%, according to the latest findings from Future Market Insights Inc. and industry experts.

Unveiling Market Trends and Highlights

In a world grappling with the escalating prevalence of thyroid disorders, the thyroid function test market has charted a consistent growth trajectory over the years. This upward surge is fueled by various factors, including shifts in lifestyle, rising hormonal imbalances, and an increasingly prevalent incidence of thyroid diseases among the younger population.

Recent data from the World Obesity Atlas 2023 further underscores the pressing nature of these health concerns, predicting a staggering 3,041 million individuals suffering from overweight or obesity by 2025.

The thyroid function test market is undoubtedly at the forefront of addressing these growing health challenges, with an encouraging outlook for the years ahead. As it continues to evolve and expand, this dynamic market will play a pivotal role in diagnosing and managing thyroid-related conditions, contributing significantly to the healthcare landscape.

Request a Sample of this Research Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-454

Hospitals will continue to be the leading end-use segment for thyroid function tests, representing revenues worth US$ 22.2 Mn in 2016, up from US$ 21.3 Mn in 2015. Hospitals will be the fastest-growing end-use segment, followed by research organizations and diagnostic laboratories. Clinics will remain the smallest end-use segment in 2016, witnessing the lowest growth rate vis-à-vis other segments.

Long-term Outlook:

 FMI forecasts moderate long-term growth for the India thyroid function test market, with global revenues expected to surpass US$ 55.3 Mn by 2025. During the period 2015-2025, the India thyroid function test market is anticipated to increase at 3.2% CAGR.

Competitive Landscape

Some of the key players covered in the India thyroid function test market report include

• Sigma-Aldrich Co. LLC. (Merck & Co., Inc.)
• Beckman Coulter, Inc.
• (Danaher)
• Siemens Healthcare GmbH
• Abbott Laboratories

The report offers insights on the various strategies related to software development, and market consolidation initiatives and analyses the various market players’ specific strengths, weaknesses, opportunities, and threats.

Uncovering the assumptions made in the study. Ask an Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-454

Drivers and Trends

The cardinal factor fuelling the growth of the Indian thyroid function test market is the high prevalence of thyroid disorders in the country. During an epidemiology study across major cities in India, Kolkata was reported to have the highest prevalence of hypothyroidism (21.67%) compared to other cities. Over the past few years, there have been significant advancements in the specificity and sensitivity of thyroid testing, which has impacted the treatment of thyroid disorders.

The Indian healthcare industry has witnessed significant advancements concerning medical devices and pathological laboratory business segments. Domestic and international companies are entering into joint ventures and strategic agreements owing to increasing standardization, availability of human resources, and high level of progress in medical technology.

India is witnessing various trends that are expected to bring substantial changes in the landscape of the healthcare industry in the subsequent years. Traditional health risks have been replaced by lifestyle diseases in the last two decades. Various conditions prevailing currently include hypothyroidism, cardiovascular disorders, diabetes, obesity, and hypertension to name a few

Key Segments Covered

By Test type

• TSH
• T3
• T4
• FT3
• FT4
• Others

By End Use

• Clinics
• Research Organizations
• Diagnostic Laboratories
• Hospitals

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/454

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube